Biology Reference
In-Depth Information
49. Chandrachud LM, Grindlay GJ, McGarvie GM, et al . (1995)
Vaccination of cattle with the N-terminus of L2 is necessary and suffi-
cient for preventing infection by bovine papillomavirus-4. Virology
211 : 204-208.
50. Embers ME, Budgeon LR, Pickel M, Christensen ND. (2002)
Protective immunity to rabbit oral and cutaneous papillomaviruses by
immunization with short peptides of L2, the minor capsid protein. J Virol
76 : 9798-9805.
51. Evans TG, Bonnez W, Rose RC, et al . (2001) A Phase 1 study of a
recombinant virus-like particle vaccine against human papillomavirus
type 11 in healthy adult volunteers. J Infect Dis 183 : 1485-1493.
52. Harro CD, Pang YY, Roden RB, et al . (2001) Safety and immuno-
genicity trial in adult volunteers of a human papillomavirus type 16 L1
virus-like particle vaccine. J Natl Cancer Inst 93 : 284-292.
53. Schiller JT, Davies P. (2004) Delivering on the promise: HPV vaccines
and cervical cancer. Nature Rev Microbiology 2 : 343-347.
54. Kawana K, Yasugi T, Kanda T, et al . (2003) Safety and immunogenicity
of a peptide containing the cross-neutralization epitope of HPV16 L2
administered nasally in healthy volunteers. Vaccine 21 : 4256-4260.
Search WWH ::




Custom Search